Key result
F. oxysporum intron demonstrates high self-splicing efficiency and enables a fluorescence-based high-throughput screening assay.
Why the study?
The search for safe and efficient new antifungal compounds for agriculture requires new molecular targets with novel modes of action, such as group I introns present in fungi but rare in plants and animals.
Group I introns in phytopathogenic fungi demonstrate self-splicing activity that can be adapted into a high-throughput screening assay to discover novel antifungal compounds.
May enable HTS for novel antifungals; leaves open clinical translation and human efficacy.
The search for safe and efficient new antifungal compounds for agriculture has led to more efforts in finding new modes of action. This involves the discovery of new molecular targets, including coding and non-coding RNA. Rarely found in plants and animals but present in fungi, group I introns are of interest as their complex tertiary structure may allow selective targeting using small molecules. In this work, we demonstrate that group I introns present in phytopathogenic fungi have a self-splicing activity in vitro that can be adapted in a high-throughput screening to find new antifungal compounds. Ten candidate introns from different filamentous fungi were tested and one group ID intron found in F. oxysporum showed high self-splicing efficiency in vitro. We designed the Fusarium intron to act as a trans-acting ribozyme and used a fluorescence-based reporter system to monitor its real time splicing activity. Together, these results are opening the way to study the druggability of such introns in crop pathogen and potentially discover small molecules selectively targeting group I introns in future high-throughput screenings.
No takes yet. Share an insight, caveat, or question.
Malbert et al. (2023) studied Phytopathogenic fungal infections. Fluorescence-based high-throughput screening strategy was evaluated on In vitro self-splicing efficiency. Evaluation of 10 candidate introns identified one from F. oxysporum with high self-splicing efficiency, which was successfully adapted into a fluorescence-based high-throughput screening assay.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: